Back to News
Market Impact: 0.25
Kenvue Is Leaving the S&P 500: Here's What It Means for Investors
Source: 247wallst.com
M&A & RestructuringHealthcare & BiotechCompany Fundamentals
Kimberly-Clark is absorbing a recognizable consumer-health brand portfolio, a transaction the article says reshapes holdings across three indexes. The excerpt provides no deal value, timing, or further terms.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
neutral
Sentiment Score
0.00
Ticker Sentiment
KMB0.30
More News
- Kimberly-Clark closes its acquisition of Tylenol maker Kenvue. What to expect next
- Premarket movers: Estee Lauder, Rivian rise premarket; Check Point falls
- Kimberly-Clark Completes Acquisition of Kenvue, Creating the Preeminent Global Consumer Health and Wellness Leader
- Jim Cramer's top 10 things to watch in the stock market Monday
- Marvell to buy Lumentum in $115 billion deal in AI data-center bet
- Marvell, Lumentum tout historic $115B deal to create ‘category leader' in AI connectivity